Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Santarus Articles

Pharming and Santarus file BLA for Ruconest with US FDA

18 April 2013

Pharming gets $10 million milestone from Santarus on Ruconest progress

26 November 2012

Validity of certain patent claims covering Santarus' Zegerid capsule and powder upheld

6 September 2012

Santarus and Depomed expand US deal on Glumetza

23 August 2011

FDA turns down 'incomplete' Rhucin dossier

1 March 2011

Santarus gets rights to inflammatory/autoimmune disease candidate by buying Covella

15 September 2010

Pharming licenses North American rights to HAE drug Rhucin to Santarus for upfront $15 million

14 September 2010

Santarus in-licenses novel type 2 diabetes drug for US market for upfront $5 million and 35%-40% royalties

10 September 2010

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • CIS countries prepare for the introduction of drug reimbursement schemes
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • CIS countries prepare for the introduction of drug reimbursement schemes
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS